Rusling Research Group

Our research team employs analytical chemistry, electrochemistry, biochemistry, and nanoscience to develop devices for multiplexed diagnostic, toxicity screening, and new approaches to electrochemical synthesis in water-based microemulsions. A major focus of our current research is designing low cost, high throughput bioanalytical devices, often using microfluidics and 3D printing, for cancer diagnostics, genotoxicity chemistry screening, and electrochemical biocatalysis. We utilize many analytical techniques including electrochemistry, electrochemiluminescence, surface plasmon resonance, and LC-MS/MS. New projects include development of fast, reliable, low cost tests for coronavirus detection. New electrosynthetic approaches feature development of stable biocatalytic films of oxidative enzymes and polyions that can be used at temperatures close up to 95 ^oC.

We collaborate with a large network of health centers and hospitals, here in Connecticut, and in the US, Canada, Italy, and Ireland in attempt to bring our diagnostic systems to the clinic. We also partner with other faculty from chemistry and material science departments at UCONN to investigate new nanomaterials for the next generation of high throughput biomedical arrays. Current funding sources include NIH, EPA, and NSF.